Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Association between resistin promoter -420C>G polymorphisms and producing ability with type 2 diabetes mellitus

1 Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, ROC
2 Hi-Q Clinical Laboratory, Quanzhou, Fujian Province, PRC
3 Department of Cardiology, Kuang Tien General Hospital, Taichung, ROC
4 School of Medicine, Chung Shan Medical University, Taichung, ROC
5 Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, ROC
6 College of Life Sciences, Fujian Normal University, Fuzhou, Fujian Province, PRC
7 Department of Nursing, College of Nursing, Hungkuang University, Taichung, Taiwan, ROC
# As the 1st authors contributed equally to this work.

Elevated resistin levels and the polymorphisms located at gene encoding resistin (RETN) are associated with diabetic pathogenesis. However, the correlation between RETN genotypes and T2DM is controversial due to discrepancies among reports. This study aimed at investigating and clarifying the putative association of RETN and T2DM in Taiwanese population. The resistin levels and RETN -420C>G genotypes in 244 control and 305 T2DM subjects were examined. Meanwhile, the association between genetic polymorphism of RETN -420C>G and resistin levels, as well as between RETN -420C>G and subjects’ clinical characteristics was statistically analyzed. The RETN -420C>G genotypes (p = 0.01) and G allele (p = 0.002) were significantly associated with T2DM. In addition, concanavalin A-stimulated peripheral blood mononuclear cells from T2DM subjects had higher resistin-secreting ability (p = 0.044). Nevertheless, no significant association between the subjects’ biochemical data and RETN -420 SNPs was found. Our results indicate that RETN -420C>G SNPs and G allele are significantly associated with T2DM. Investigation of RETN polymorphisms in T2DM patients from various ethnic populations are crucial and will contribute to the understanding of this gene in the diabetic etiology. The present results may contribute to gain knowledge on the complex genetic heterogeneity of type 2 diabetes.
  Article Metrics

Keywords obesity; promoter polymorphism; resistin; type 2 diabetes mellitus

Citation: Kuo-Ting Ho, Chih-Ping Hsia, Chien-Ning Huang, Yih-Hsin Chang, Yao Lin, Ming-Yuh Shiau. Association between resistin promoter -420C>G polymorphisms and producing ability with type 2 diabetes mellitus. AIMS Allergy and Immunology, 2017, 1(4): 181-193. doi: 10.3934/Allergy.2017.4.181


  • 1. Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104: 517–529.    
  • 2. Friedman JM (2000) Obesity in the new millennium. Nature 404: 632–634.    
  • 3. Spiegelman BM, Flier JS (2000) Obesity and the regulation of energy balance. Cell 104: 531–543.
  • 4. Halaas JL, Gajiwala KS, Maffei M, et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543–546.    
  • 5. Halaas JL, Boozer C, Blair-West J, et al. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878–8883.    
  • 6. Cho YM, Youn BS, Chung SS, et al. (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47: 559–565.    
  • 7. Steppan CM, EJ Brown, Wright CM, et al. (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98: 502–506.    
  • 8. Fujinami A, Obayashi H, Ohta K, et al. (2004) Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339: 57–63.    
  • 9. Silha JV, Krsek M, Skrha JV, et al. (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149: 331–335.    
  • 10. Azuma K, Katsukawa F, Oguchi S, et al. (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11: 997–1001.    
  • 11. Steppan CM, Bailey ST, Bhat S, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307–312.    
  • 12. ED Muse, Obici S, Bhanot S, et al. (2004) Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114: 232–239.    
  • 13. Youn BS, Yu KY, Park HJ, et al. (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocr Metab 89: 150–156.
  • 14. Pizzuti A, Argiolas A, Di PR, et al. (2002) An ATG repeat in the 3'-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocr Metab 87: 4403–4406.    
  • 15. Engert JC, Vohl MC, Williams SM, et al. (2002) 5' flanking variants of resistin are associated with obesity. Diabetes 51: 1629–1634.    
  • 16. Smith SR, Bai F, Charbonneau C, et al. (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52: 1611–1618.    
  • 17. Conneely KN, Silander K, Scott LJ, et al. (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47: 1782–1788.    
  • 18. Xita N, Georgiou I, Tsatsoulis A, et al. (2004) A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertil Steril 82: 1466–1467.
  • 19. Mattevi VS, Zembrzuski VM, Hutz MH (2004) A resistin gene polymorphism is associated with body mass index in women. Hum Genet 115: 208–212.
  • 20. Ho KT, Shiau MY, Chang YH, et al. (2010) Association of IL-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus. Metabolism 59: 1717–1722.    
  • 21. Chang YH, Huang CN, Shiau MY (2012) Association of IL-4 receptor gene polymorphisms with high density lipoprotein cholesterol. Cytokine 59: 309–312.    
  • 22. Osawa H, Yamada K, Onuma H, et al. (2004) The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75: 678–686.    
  • 23. Ochi M, Osawa H, Hirota Y, et al. (2007) Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Diabetes 56: 2834–2838.    
  • 24. Xu JY, Sham PC, Xu A, et al. (2007) Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study. Clin Endocrinol 66: 211–217.    
  • 25. Hivert MF, Manning AK, McAteer JB, et al. (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham offspring study. Diabetes 58: 750–756.    
  • 26. Wen Y, Lu P, Dai L (2013) Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis. Acta Diabetol 50: 267–272.    
  • 27. Tan MS, Chang SY, Chang DM, et al. (2003) Association of resistin gene 3'-untranslated region +62G-->A polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocr Metab 88: 1258–1263.    
  • 28. Chi S, Lan C, Zhang S, et al. (2009) Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese. Mol Cell Biochem 330: 31–38.
  • 29. Chen BH, Song YQ, Ding EL, et al. (2010) Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. Int J Mol Epidemiol Gene 1: 167–174.
  • 30. Tsukahara T, Nakashima E, Watarai A, et al. (2009) Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pr 84: 179–186.
  • 31. Osawa H, Tabara Y, Kawamoto R, et al. (2009) PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population. Clin Endocrinol 71: 341–345.    
  • 32. Osawa H, Onuma H, Ochi M, et al. (2005) Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Bioph Res Co 335: 596–602.
  • 33. Shiau MY, Wu CY, Huang CN, et al. (2003) Analysis of TNF-α G-238A and G-308A promoter polymorphism in Taiwanese patient with type 2 diabetes mellitus. Tissue Antigens 61: 393–397.    
  • 34. Shiau MY, Huang CN, Liao JH, et al. (2004) Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwanese. J Endocrinol Invest 27: 1076–1080.    
  • 35. Chang YH, Huang CN, Lee YL, et al. (2004) The C-174G Promoter polymorphism of the IL-6 gene that affects insulin sensitivity in Caucasians is not involved in the pathogenesis of Taiwanese type 2 diabetes mellitus. Eur Cytokine Netw 15: 117–119.
  • 36. Shiau MY, Huang CN, Wu CY, et al. (2005) Association of IL-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 66: 1258–1263.    
  • 37. Osawa H, Tabara Y, Kawamoto R, et al. (2007) Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30: 1501–1506.    
  • 38. Azuma K, Oguchi S, Matsubara Y, et al. (2004) Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 36: 564–570.    
  • 39. Suriyaprom K, Phonrat B, Namjuntra P, et al. (2009) The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. J Clin Biochem Nutr 44: 104–110.    


Reader Comments

your name: *   your email: *  

Copyright Info: 2017, Ming-Yuh Shiau, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved